Abstract: DOI: 10.1002/jmv.27158
LETTER TO THE EDITOR
Paracetamol in the home treatment of early COVID‐19
symptoms: A possible foe rather than a friend for elderly
patients?
To the Editor,
development and prevent crowding in hospitalization.9 In Italy, a civil
On October 2020, Sestili and Fimognari reported that acet-
outcry from some physicians, practitioners, and family doctors, is
aminophen (N‐aetyl‐para‐aminophenol), commonly known as para-
expanding the debate, even in politics, about how best to treat
cetamol, induces or worsens glutathione (GSH) consumption in
COVID‐19 at home. The civil legacy of these professionals was ar-
elderly patients affected by early or mild coronavirus disease 2019
ranged to prevent the huge concern of elderly people treated with
(COVID‐19), thus greatly enhancing the risk of COVID‐19 exacer-
simple paracetamol, counseled to wait under paracetamol therapy
bation in these patients.1 By early COVID‐19, we mean the typical or
for reduced symptoms, yet then often undergoing rapid exacerbation
commonly acknowledged symptomatology associated with the early
and in many cases even death while being hospitalized.
phases of COVID‐19, occurring usually when a patient stays at home,
Suter and colleagues recently created an algorithm of the best
that is, fever and dyspnea, besides weakness and pain,2 despite the
and simplest home therapy for mild symptoms in early COVID‐19, to
COVID‐19 symptoms being particularly variable and complex andl
prevent hospitalization.10 In their retrospective observational study,
only 50% of patients infected with severe acute respiratory syn-
the control cohort (45 patients on 77; 58.44%) received paracetamol
drome coronavirus 2 (SARS‐CoV‐2) developing a forthright symp-
as home therapy, whereas in the cohort of patients following a re-
tomatology.2 In any case, fever is one of the most common symptoms
commended protocol only 6 of 86 (6.98%) used paracetamol as the
during the early stages of COVID‐19, where people use paracetamol
leading therapy. The rate of hospitalization was 1.2% for patients
quite exclusively.
undergoing the recommended protocol and 13.1% (p = .007) for pa-
Reduction of GSH is a condition particularly severe for the in-
tients using predominantly paracetamol, that is, 44 cumulative days
dividual's antioxidant and anti‐inflammatory response and it is com-
of hospitalization (recommended) versus 481 (controls).10 This evi-
prehensible that its depletion is crucial for COVID‐19 worsening.
dence shows that using paracetamol at home to treat mild COVID‐
Moreover, Zhang and colleagues, recently showed that SARS‐CoV‐2
19 symptoms, particularly in older adults with comorbidity, greatly
hijacks folate and one‐carbon metabolism in the infected cell, by re-
enhanced the risk of hospitalization for dyspnea from interstitial
modeling their biochemical turnover at the posttranscriptional level
pneumonia, so increasing the huge concern of crowding the intensive
and going ahead with the de novo synthesis of purines.3 Figure 1
care units. Possible causes of this exacerbation might be the acti-
shows the fundamental role of GSH in one‐carbon metabolism.
vation of prothrombotic mechanisms, currently reported as the
SARS‐CoV‐2 uses the cytosolic serine hydroxymethyltransferase‐1 to
leading pathogenetic cause of COVID‐19, alongside endothelial
activate the one‐carbon metabolism for de novo synthesis of purines2
dysfunction.11 Actually, GSH..
{ 'indexed': {'date-parts': [[2022, 8, 23]], 'date-time': '2022-08-23T14:49:44Z', 'timestamp': 1661266184350},
'reference-count': 14,
'publisher': 'Wiley',
'issue': '10',
'license': [ { 'start': { 'date-parts': [[2021, 6, 30]],
'date-time': '2021-06-30T00:00:00Z',
'timestamp': 1625011200000},
'content-version': 'vor',
'delay-in-days': 0,
'URL': 'http://onlinelibrary.wiley.com/termsAndConditions#vor'},
{ 'start': { 'date-parts': [[2021, 6, 30]],
'date-time': '2021-06-30T00:00:00Z',
'timestamp': 1625011200000},
'content-version': 'tdm',
'delay-in-days': 0,
'URL': 'http://doi.wiley.com/10.1002/tdm_license_1.1'}],
'content-domain': {'domain': ['onlinelibrary.wiley.com'], 'crossmark-restriction': True},
'published-print': {'date-parts': [[2021, 10]]},
'DOI': '10.1002/jmv.27158',
'type': 'journal-article',
'created': {'date-parts': [[2021, 6, 25]], 'date-time': '2021-06-25T15:51:58Z', 'timestamp': 1624636318000},
'page': '5704-5706',
'update-policy': 'http://dx.doi.org/10.1002/crossmark_policy',
'source': 'Crossref',
'is-referenced-by-count': 16,
'title': 'Paracetamol in the home treatment of early COVID‐19 symptoms: A possible foe rather than a '
'friend for elderly patients?',
'prefix': '10.1002',
'volume': '93',
'author': [ { 'given': 'Sergio',
'family': 'Pandolfi',
'sequence': 'first',
'affiliation': [ { 'name': 'SIOOT, High School in Oxygen Ozone Therapy University of Pavia '
'Pavia Italy'},
{'name': 'Healthcare Clinics Villa Mafalda Rome Italy'}]},
{ 'given': 'Vincenzo',
'family': 'Simonetti',
'sequence': 'additional',
'affiliation': [ { 'name': 'SIOOT, High School in Oxygen Ozone Therapy University of Pavia '
'Pavia Italy'}]},
{ 'given': 'Giovanni',
'family': 'Ricevuti',
'sequence': 'additional',
'affiliation': [{'name': 'Department of Drug Science University of Pavia Pavia Italy'}]},
{ 'ORCID': 'http://orcid.org/0000-0003-1789-8307',
'authenticated-orcid': False,
'given': 'Salvatore',
'family': 'Chirumbolo',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Neurosciences, Biomedicine and Movement Sciences '
'University of Verona Verona Italy'}]}],
'member': '311',
'published-online': {'date-parts': [[2021, 6, 30]]},
'reference': [ {'key': 'e_1_2_1_6_2_1', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fphar.2020.579944'},
{ 'key': 'e_1_2_1_6_3_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1371/journal.pone.0248009'},
{ 'key': 'e_1_2_1_6_4_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1038/s41467-021-21903-z'},
{'key': 'e_1_2_1_6_5_1', 'doi-asserted-by': 'publisher', 'DOI': '10.3945/ajcn.110.003483'},
{'key': 'e_1_2_1_6_6_1', 'doi-asserted-by': 'publisher', 'DOI': '10.2337/dc10-1006'},
{ 'key': 'e_1_2_1_6_7_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1080/20477724.2020.1751388'},
{ 'issue': '11',
'key': 'e_1_2_1_6_8_1',
'first-page': '786',
'article-title': 'Glucose‐6‐phosphate dehydrogenase deficiency enhances Covid‐19 '
'infection in elderly people',
'volume': '121',
'author': 'Abdel Hafez SMN',
'year': '2020',
'journal-title': 'Bratisl Lek Listy'},
{ 'key': 'e_1_2_1_6_9_1',
'volume-title': 'Glucose 6 Phosphate Dehydrogenase Deficiency. 2020 Jun 25. In: '
'StatPearls [Internet]',
'author': 'Richardson SR',
'year': '2021'},
{ 'key': 'e_1_2_1_6_10_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/S0262-4079(20)30731-4'},
{ 'key': 'e_1_2_1_6_11_1',
'article-title': 'A Simple, Home‐Therapy Algorithm to Prevent Hospitalization for '
'COVID‐19 Patients',
'author': 'Suter F',
'year': '2021',
'journal-title': 'A Retrospective Observational Matched‐Cohort Study medRxiv'},
{ 'key': 'e_1_2_1_6_12_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1038/s41577-021-00536-9'},
{'key': 'e_1_2_1_6_13_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1055/s-0038-1657028'},
{ 'issue': '1',
'key': 'e_1_2_1_6_14_1',
'first-page': '176',
'article-title': 'Oxidative status and antioxidant enzyme levels in deep venous '
'thrombosis patients',
'volume': '11',
'author': 'Türker FS',
'year': '2021',
'journal-title': 'Am J Cardiovasc Dis'},
{'key': 'e_1_2_1_6_15_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1017/ice.2021.122'}],
'container-title': 'Journal of Medical Virology',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27158',
'content-type': 'application/pdf',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://onlinelibrary.wiley.com/doi/full-xml/10.1002/jmv.27158',
'content-type': 'application/xml',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27158',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2022, 5, 10]],
'date-time': '2022-05-10T16:39:42Z',
'timestamp': 1652200782000},
'score': 1,
'resource': {'primary': {'URL': 'https://onlinelibrary.wiley.com/doi/10.1002/jmv.27158'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2021, 6, 30]]},
'references-count': 14,
'journal-issue': {'issue': '10', 'published-print': {'date-parts': [[2021, 10]]}},
'alternative-id': ['10.1002/jmv.27158'],
'URL': 'http://dx.doi.org/10.1002/jmv.27158',
'relation': {},
'ISSN': ['0146-6615', '1096-9071'],
'subject': ['Infectious Diseases', 'Virology'],
'container-title-short': 'Journal of Medical Virology',
'published': {'date-parts': [[2021, 6, 30]]},
'assertion': [ { 'value': '2021-05-29',
'order': 0,
'name': 'received',
'label': 'Received',
'group': {'name': 'publication_history', 'label': 'Publication History'}},
{ 'value': '2021-06-23',
'order': 1,
'name': 'accepted',
'label': 'Accepted',
'group': {'name': 'publication_history', 'label': 'Publication History'}},
{ 'value': '2021-06-30',
'order': 2,
'name': 'published',
'label': 'Published',
'group': {'name': 'publication_history', 'label': 'Publication History'}}]}
